Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOAHS-ARC: TNT in Locally Advanced Rectal Cancer
NCT04864067Phase 2Completed
- Sponsor
- Servicio de Salud Metropolitano Sur Oriente
- Start
- Jun 2021
- Primary completion
- May 2026
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid, capecitabine in rectal cancer, sponsored by Servicio de Salud Metropolitano Sur Oriente. Started Jun 2021; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acidcapecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04864067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04864067.